PL376465A1 - Kompozycja zawierająca mieszaninę składników czynnych oraz sposób jej otrzymywania - Google Patents

Kompozycja zawierająca mieszaninę składników czynnych oraz sposób jej otrzymywania

Info

Publication number
PL376465A1
PL376465A1 PL04376465A PL37646504A PL376465A1 PL 376465 A1 PL376465 A1 PL 376465A1 PL 04376465 A PL04376465 A PL 04376465A PL 37646504 A PL37646504 A PL 37646504A PL 376465 A1 PL376465 A1 PL 376465A1
Authority
PL
Poland
Prior art keywords
mixture
preparation
composition
active principles
principles
Prior art date
Application number
PL04376465A
Other languages
English (en)
Other versions
PL223347B1 (pl
Inventor
Philippe Chenevier
Dominique Marechal
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm filed Critical Ethypharm
Publication of PL376465A1 publication Critical patent/PL376465A1/pl
Publication of PL223347B1 publication Critical patent/PL223347B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
PL376465A 2003-02-05 2004-01-21 Kompozycja farmaceutyczna albo kosmetyczna zawierająca powlekane cząstki PL223347B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0301308A FR2850576B1 (fr) 2003-02-05 2003-02-05 Composition comprenant un melange de principes actifs, et procede de preparation
US44719803P 2003-02-13 2003-02-13

Publications (2)

Publication Number Publication Date
PL376465A1 true PL376465A1 (pl) 2005-12-27
PL223347B1 PL223347B1 (pl) 2016-10-31

Family

ID=32852330

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376465A PL223347B1 (pl) 2003-02-05 2004-01-21 Kompozycja farmaceutyczna albo kosmetyczna zawierająca powlekane cząstki

Country Status (18)

Country Link
US (2) US7846460B2 (pl)
EP (1) EP1589954B1 (pl)
JP (1) JP4791348B2 (pl)
KR (1) KR20050096963A (pl)
CN (1) CN1747723B (pl)
AU (1) AU2004210438B2 (pl)
BR (1) BRPI0407116B1 (pl)
CA (1) CA2514446C (pl)
EA (1) EA010972B1 (pl)
ES (1) ES2590807T3 (pl)
FR (1) FR2850576B1 (pl)
IL (1) IL169880A (pl)
IS (1) IS7998A (pl)
MX (1) MXPA05008161A (pl)
NO (1) NO341294B1 (pl)
NZ (1) NZ541886A (pl)
PL (1) PL223347B1 (pl)
WO (1) WO2004069135A2 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
AU2006274541B2 (en) 2005-08-02 2012-12-13 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
KR101445757B1 (ko) 2006-08-04 2014-10-02 에씨팜 옥시코돈을 포함하는 과립 및 경구 붕해 정제
SI3103448T1 (sl) * 2006-09-26 2019-11-29 Novartis Ag Farmacevtski sestavek, ki vsebuje modulator S1P
WO2008089774A1 (fr) * 2007-01-22 2008-07-31 Crd Saidal Formulation d'un comprime orodispersible a base de paracetamol enrobe
KR20090121291A (ko) 2007-02-01 2009-11-25 솔-겔 테크놀로지스 리미티드 산화금속 코팅을 포함한 입자의 제조방법 및 산화금속 코팅을 포함한 입자
BRPI0808163A2 (pt) 2007-02-01 2014-11-04 Sol Gel Technologies Ltd Composição para aplicação tópica, métodos para tratar uma condição de superfície em um indivíduo, para preparar uma composição, e para usar o kit, e, kit
EP2223683B1 (en) * 2007-12-27 2014-06-18 Taiho Pharmaceutical Co., Ltd. Oral particulate antitumor preparation
JP5845172B2 (ja) * 2009-05-01 2016-01-20 アデア ファーマスーティカルズ，インコーポレイテッド 高および低用量薬物の組み合わせを含む口腔内崩壊錠組成物
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
TW201722406A (zh) 2012-03-02 2017-07-01 羅德製藥公司 抗破壞性立即釋出型調製劑類
WO2014042120A1 (ja) * 2012-09-13 2014-03-20 ライオン株式会社 発泡性口腔用組成物、発泡性口腔用固形製剤及び発泡性口腔用製品
CA2888278A1 (en) * 2012-10-15 2014-04-24 Isa Odidi Oral drug delivery formulations
KR101484608B1 (ko) * 2012-11-26 2015-01-22 한국과학기술연구원 Pva와 알지네이트 기반 코어-쉘 구조의 복합담체 및 그 제조방법
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP2950923B1 (en) 2013-02-01 2022-03-09 W.R. Grace & CO. - CONN. Porous silica gel as a carrier for liquid technologies
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
WO2019012537A1 (en) 2017-07-12 2019-01-17 Sol-Gel Technologies Ltd COMPOSITIONS COMPRISING ENCAPSULATED TRETTINOIN
CN111990641A (zh) * 2020-05-06 2020-11-27 焦作百仑斯生物科技有限公司 一种解酒护肝片及施工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044404A (ja) * 1998-07-27 2000-02-15 Otsuka Chem Co Ltd 農業用混合粒剤
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6296874B1 (en) * 2000-05-01 2001-10-02 Aeropharm Technology Incorporated Core formulation comprising troglitazone and abiguanide
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes

Also Published As

Publication number Publication date
EP1589954B1 (en) 2016-08-31
AU2004210438B2 (en) 2007-08-16
NO20053799L (no) 2005-08-11
HK1087015A1 (zh) 2006-10-06
WO2004069135A3 (en) 2004-10-28
EA010972B1 (ru) 2008-12-30
CN1747723B (zh) 2010-05-12
CN1747723A (zh) 2006-03-15
CA2514446A1 (en) 2004-08-19
FR2850576B1 (fr) 2007-03-23
JP2006516597A (ja) 2006-07-06
NO341294B1 (no) 2017-10-02
BRPI0407116A (pt) 2006-01-10
BRPI0407116B1 (pt) 2018-04-03
IL169880A0 (en) 2007-07-04
KR20050096963A (ko) 2005-10-06
US7846460B2 (en) 2010-12-07
JP4791348B2 (ja) 2011-10-12
MXPA05008161A (es) 2005-10-05
WO2004069135A2 (en) 2004-08-19
US20060134422A1 (en) 2006-06-22
CA2514446C (en) 2012-04-10
AU2004210438A1 (en) 2004-08-19
EA200501250A1 (ru) 2006-02-24
FR2850576A1 (fr) 2004-08-06
EP1589954A2 (en) 2005-11-02
NZ541886A (en) 2008-12-24
IL169880A (en) 2013-10-31
IS7998A (is) 2005-08-25
US20110081389A1 (en) 2011-04-07
PL223347B1 (pl) 2016-10-31
ES2590807T3 (es) 2016-11-23

Similar Documents

Publication Publication Date Title
PL377161A1 (pl) Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
AU2003274211A8 (en) Flame-retardant composition, preparation method and use thereof
IL164703A0 (en) ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
AU2003239614A8 (en) Cardiolipin compositions, methods of preparation and use
SI2218461T1 (sl) Formulacija protitelesa CD40 in postopki
IL169648A0 (en) Novel structures and method of preparation
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
ZA200506790B (en) Arylvinylazacycloalkane compounds and method of preparation and use thereof
IL167187A (en) Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
IL176515A0 (en) 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
EP1594440A4 (en) SELECTIVE AND SPECIFIC PREPARATION OF DISCRETE PEG COMPOUNDS
AU2003302188A8 (en) Method of obtaining a soothing active ingredient, active ingredient and compositions obtained
AU2003264705A1 (en) Nitrophenol preparation method
AU2003210871A8 (en) Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof
IL163596A0 (en) Cd40 splice variants, compositions for making and methods of using thesame
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003252138A1 (en) Cementitious composition comprising bottom ash, methods of making and use thereof
AU2002953252A0 (en) Compositions, Compounds and Methods for their Preparation
AU2001273305A1 (en) Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
PL1778265T3 (pl) Związki guanylohydrazonowe, kompozycje, sposoby wytwarzania i stosowania
ZA200606542B (en) 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
AU2003246840A8 (en) Anti-hiv composition, production method thereof and medicament
AU2003303815A1 (en) Alanines compounds, method of preparing them and their use
AU2002357561A8 (en) Oxazolidine derivative, methods of preparation and uses